Earnings Call · Q3 FY2025·2025-11-10

Q3 25EPS +100.00%*·Rev n/aQ2 25EPS +61.19%·Rev n/aQ1 25EPS -88.89%·Rev n/aQ4 24EPS +39.86%·Rev n/a⚠ consensus missing

Theravance Biopharma, Inc. TBPH

Rick Winningham — CHIEF EXECUTIVE OFFICER

Rhonda Farnum — SVP, COMM & MEDICAL AFFAIRS

Aine Miller — SVP, DEV & HEAD OF IRE OFFICE

Aziz Sawaf — SVP & CHIEF FINANCIAL OFFICER

+22.7%1d on move date+22.5% vs SPY3d+19.0%5d+19.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TBPH calls or request research access.

More TBPH calls Browse calls Request research access